期刊文献+

保妇康栓治疗妊娠期外阴阴道假丝酵母菌病100例疗效观察 被引量:2

下载PDF
导出
摘要 目的:观察保妇康栓治疗妊娠期外阴阴道假丝酵母菌病的疗效。方法:对我院妇科门诊确诊为外阴阴道假丝酵母菌病的100例患者给予保妇康栓剂,每晚睡前阴道深部放置1粒,连续8d为1个疗程。治疗后第4天和第22天各随访1次,复查阴道分泌物有无假菌丝及孢子。结果:应用保妇康栓治疗妊娠期外阴阴道假丝酵母菌病100例,痊愈90例(90%),10例又给予2~3个疗程治疗后,均痊愈,痊愈率为100%,且无副作用发生。结论:保妇康栓治疗妊娠期外阴阴道假丝酵母菌病,疗效好,无全身毒性反应,安全可靠。
作者 王凤 宋琪
出处 《中国医药导报》 CAS 2010年第11期135-135,共1页 China Medical Herald
  • 相关文献

参考文献4

二级参考文献29

  • 1中华妇产科学分会感染性疾病协作组.外阴阴道念珠菌病诊治规范(草案)[J].中华妇产科杂志,2004,39(6):430-431. 被引量:490
  • 2金同珍.中国药物大辞典[M].北京:中国医药科技出版社,1991.231-232.
  • 3Isobejd, Faros, Forcerw et al. Vulovaginal candidiasis; epidemiologie, diagnostic, andtherapepatconsi derations [ J ] . Am Jobsteric and gynecology, 1998, 178 (2): 203
  • 4Sexually Transmitted Disease Treatment Guidelines 2002[J].Centers for Disease Control and Prevention.MMWR,2002,51(RR-6):45-48.
  • 5Sojakova M,Liptajova D,Simoncicova M,et al.Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics[J].Ceska Gynekol,2003,68:24-29.
  • 6Linda O,Eckert S,Hawes C,et al.Vulvovaginal candidiasis:Clinical manifestations,risk factors,management algorithm[J].Obstet Gynecol,1998,92:757-765.
  • 7Edwards L.The diagnosis and treatment of infectious vaginitis[J].Dermatol Ther,2004,17:102-110.
  • 8French L,Horton J,Matousek M.Abnormal vaginal discharge:what does and does not work in treating underlying causes[J].J Fam Pract,2004,53:890-894.
  • 9Geiger AM,Foxman B.Risk factors for vulvovaginal candidiasis:a case-control study among university students[J].Epidemiology,1996,7:182-187.
  • 10Kazerooni T,Mosalaee A.Does contraceptive method change the Pap smear finding[J].Contraception,2002,66:243-246.

共引文献59

同被引文献17

  • 1罗永慧,甘雪华,汤翔群,段颍卿.女性生殖道假丝酵母菌感染的菌群分布及药敏分析[J].江西医学检验,2007,25(2):137-138. 被引量:2
  • 2Polish Gynecological Society. The Polish Gynecological Society Expert Committee recomendations regarding application of fluconazole in the treatment of vulvovaginal candidiasis [J]. Ginekol Pol,2012,83(6) :478- 480.
  • 3Cassone A,De Bemardis F,Santoni G. Anticandidal immunity and vaginitis:novel opportunities for immune intervention [J]. Infect Immun, 2007,75 ( 10) : 4675-4686.
  • 4Ainsworth J, Nail M, Fox A. Question: In females being treated with antibiotics,is probiotic use effective in reducing the incidence ofvul- vovaginal candidiasis?[J]. J Okla State Med Assoc,2012, 105 (9): 349-350.
  • 5Watson CJ,Pirotta M, Myers SP. Use of complementary and alterna- tive medicine in recurrent vulvovaginal candidiasis-resuhs of a prac- titioner survey [J]. Complement Ther Med, 2012,20(4) : 218-221.
  • 6Giraldo PC,Polpeta NC,Juliato CR,et al. Evaluation of sexual func- tion in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia [J]. J Sex M ed, 2012,9( 3 ):805-811.
  • 7Fischer G. Chronic vulvovaginal candidiasis:what we know and what we have yet to learn [J]. Ustralas J Dermatol,2012,53(4):247-254.
  • 8Evi W, Harigopal M, Hui P, et al. Comparison of Affirm VPIII and Papanicolaou tests in the detection of infectiousvaginitis [J]. Am J Clin Pathol, 2011,135(3) :442-447.
  • 9Paiva L.C,P.G Vidigal,L.Donatti,et al.Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics[].Micron.2012
  • 10Giraldo P.C,N.C Polpeta,C.R.Juliato,et al.Evaluation of sexual function in brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia[].J Sex Med.2012

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部